Skip to content

Induction of labour for predicted macrosomia: the Big Baby trial

Induction of labour for predicted macrosomia: the Big Baby trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18229892
Enrollment
4000
Registered
2018-04-12
Start date
2018-05-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal care for suspected macrosomia Pregnancy and Childbirth

Interventions

Current interventions as of 29/06/2023: Big Baby With the mother’s consent, she would be allocated at random (telephone or computer-based randomisation) into either an early induction of labour group,

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18 years or over 2. Women with a fetus above 90th estimated fetal weight centile on ultrasound scan at 35+0 to 38+0 weeks gestation 3. Women with a cephalic presentation

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 14/11/2018: 1. Multiple pregnancy 2. Breech pregnancy or transverse lie presentation 3. Induction of labour contra-indicated 4. Fetus with known serious abnormality 5. Home birth or elective caesarean section already planned 6. Caesarean section or induction indicated due to health conditions such as cardiac disease or hypertensive disorders 7. Women taking medications and insulin therapy for diabetes or gestational diabetes; women with these conditions who are not taking medication are eligible 8. Current diagnosis of major psychiatric disorder which requires antipsychotic medication 9. Women unable to give informed consent e.g. learning or communication difficulties that prevent understanding of the information provided 10. Prisoners 11. Previous stillbirth 12. Previous neonatal death =28 days 13. Current intrauterine fetal death Previous exclusion criteria: 1. Multiple pregnancy 2. Breech pregnancy or transverse lie presentation 3. Induction of labour contra-indicated 4. Fetus with known serious abnormality 5. Home birth or elective caesarean section already planned 6. Caesarean section or induction indicated due to health conditions such as cardiac disease, epilepsy, or hypertensive disorders 7. Women taking medications and insulin therapy for diabetes or gestational diabetes; women with these conditions who are not taking medication are eligible 8. Current diagnosis of major psychiatric disorder which requires antipsychotic medication 9. Women unable to give informed consent e.g. learning or communication difficulties that prevent understanding of the information provided 10. Prisoners 11. Previous stillbirth 12. Previous neonatal death

Design outcomes

Primary

MeasureTime frame
Current primary outcome measure as of 29/06/2023: Big Baby Incidence of shoulder dystocia, definition by the Royal College of Obstetricians and Gynaecologists as, ‘a vaginalcephalic delivery that requires additional obstetric manoeuvres to deliver the fetus after the head has delivered and gentle traction has failed’. Shoulder dystocia will be confirmed by a notes review, undertaken by an independent expert panel; data on management of shoulder dystocia and its potential complications are an important performance metric for maternity units and will be recorded reliably in the notes; Timepoint(s): End of the study Big Baby 2Up Non-verbal cognition and language development measured using the Parent Report of Children’s Ability-Revised (PARCA-R) at 24 months Previous primary outcome measure: Incidence of shoulder dystocia, definition by the Royal College of Obstetricians and Gynaecologists as, ‘a vaginalcephalic delivery that requires additional obstetric manoeuvres to deliver the fetus after the head has delivered and gentle traction has failed’. Shoulder dystocia will be confirmed by a notes review, undertaken by an independent expert panel; data on management of shoulder dystocia and its potential complications are an important performance metric for maternity units and will be recorded reliably in the notes; Timepoint(s): End of the study

Secondary

MeasureTime frame
Current secondary outcome measure as of 29/06/2023: Big Baby Fetal outcomes: Intrapartum: 1. Time recorded between delivery of the head and delivery of the body 2. Time in labour ward 3. Time from commencement of active second stage of labour until fetal expulsion 4. Stillbirths Neonatal: 1. Neonatal death 2. Birth weight 3. Gestation at birth 4. Apgar score at five minutes 5. Fractures 6. Brachial plexus injuries 7. Admission to the neonatal unit/duration of stay 8. Hypoxic-ischaemic encephalopathy 9. Use of phototherapy 10. Respiratory morbidity 11. Hypoglycaemia Infants: 1. Proportion under specialist medical care at 2 months for a problem related to intra-partum experience 2. Maternal report of infant health concerns at 6 months 3. In hospital health care costs Maternal outcomes: Intrapartum: 1. Duration of hospital stay prior to delivery 2. Mode of delivery 3. Perineal tear (episiotomy or spontaneous 1st to 4th degree perineal tear) 4. Vaginal/cervical laceration or tear 5. Primary postpartum haemorrhage (=1000ml) 6. Retained placenta 7. Death Post-partum: 1. Sepsis 2. Fever (>38.0°c) 3. Duration of hospital stay after delivery 4. Uptake of breastfeeding 5. Hospital readmission within 30 days of postnatal inpatient discharge Longer term outcomes: Women’s physical and psychological health and satisfaction with delivery: 1. Experience; six simple questions (SSQ) at 2 months 2. Duration of exclusive breastfeeding at 2 and 6 months 3. Health-related quality of life (EQ-5D-5L) at baseline, 2 and 6 months (appropriate licences to allow reproduction of these questionnaires will be obtained) 4. Edinburgh post-natal depression scale at baseline, 2 and 6 months 5. Impact of Events Scale at 2 months 7. Post-partum bonding questionnaire at 2 months 8. Maternal report of infant health at 2 and 6 months 9. Urinary incontinence ICIQ-UI short form assessed at baseline, 2 and 6 months 10. Sexual function at baseline and 6 months 11. Maternal and infant death at 6 months fr

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Contacts

Public ContactKimberley;Kimberley Stewart;Stewart

;

Bigbaby@warwick.ac.uk;Bigbaby2Up@warwick.ac.uk+44 (0)24 76 151825;+44 (0)24 76 151825

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026